Brought to you by

Cannabis company GW Pharmaceuticals raises $34.5mm in IPO
05 Apr 2002
Executive Summary
British biotechnology company GW Pharmaceuticals, which is developing prescription drugs derived from cannabis, raised gross proceeds of $34.5mm (UK25mm) in an oversubscribed initial public offering of almost 13.7mm ordinary shares on the Alternative Investment Market. It had originally expected to raise UK16mm.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com